Correlation Between NuVim and BioAdaptives

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NuVim and BioAdaptives at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NuVim and BioAdaptives into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NuVim Inc and BioAdaptives, you can compare the effects of market volatilities on NuVim and BioAdaptives and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NuVim with a short position of BioAdaptives. Check out your portfolio center. Please also check ongoing floating volatility patterns of NuVim and BioAdaptives.

Diversification Opportunities for NuVim and BioAdaptives

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between NuVim and BioAdaptives is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding NuVim Inc and BioAdaptives in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioAdaptives and NuVim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NuVim Inc are associated (or correlated) with BioAdaptives. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioAdaptives has no effect on the direction of NuVim i.e., NuVim and BioAdaptives go up and down completely randomly.

Pair Corralation between NuVim and BioAdaptives

Given the investment horizon of 90 days NuVim is expected to generate 45.22 times less return on investment than BioAdaptives. But when comparing it to its historical volatility, NuVim Inc is 33.84 times less risky than BioAdaptives. It trades about 0.21 of its potential returns per unit of risk. BioAdaptives is currently generating about 0.28 of returns per unit of risk over similar time horizon. If you would invest  0.03  in BioAdaptives on August 31, 2024 and sell it today you would earn a total of  9.97  from holding BioAdaptives or generate 33233.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy81.82%
ValuesDaily Returns

NuVim Inc  vs.  BioAdaptives

 Performance 
       Timeline  
NuVim Inc 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in NuVim Inc are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal basic indicators, NuVim may actually be approaching a critical reversion point that can send shares even higher in December 2024.
BioAdaptives 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in BioAdaptives are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, BioAdaptives unveiled solid returns over the last few months and may actually be approaching a breakup point.

NuVim and BioAdaptives Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NuVim and BioAdaptives

The main advantage of trading using opposite NuVim and BioAdaptives positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NuVim position performs unexpectedly, BioAdaptives can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioAdaptives will offset losses from the drop in BioAdaptives' long position.
The idea behind NuVim Inc and BioAdaptives pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals